Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
Union of pediatricians of Russia
2020-08-01
|
| coleção: | Педиатрическая фармакология |
| Assuntos: | |
| Acesso em linha: | https://www.pedpharma.ru/jour/article/view/1858 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|